T9	Subject 14 33	A 48-year-old woman
T10	Effect 49 73	disfiguring facial edema
T11	Treatment 74 82;99 157	10 weeks antiviral therapy with peginterferon alfa-2a and ribavirin
T12	Treat-Disorder 162 191	chronic hepatitis C infection
T13	Age 16 27	48-year-old
T14	Gender 28 33	woman
T15	Time_elapsed 74 82	10 weeks
T17	Drug 122 143	peginterferon alfa-2a
T18	Drug 148 157	ribavirin
T8	Adverse_event 83 88	after
T16	Combination 144 147	and
E1	Adverse_event:T8 
E2	Combination:T16 arg:T17 arg2:T18